Fischer Medical Ventures Ltd

Fischer Medical Ventures Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent downgrade from Hold to Sell by MarketsMOJO with a Mojo Score of 35.0, the stock’s price momentum and technical indicators reveal a nuanced picture that investors should carefully analyse.

Fischer Medical Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

The Sensex eked out a modest gain of 0.11% on 11 Jun 2026, but Fischer Medical Ventures Ltd surged 8.7%, outperforming its Commodity Chemicals sector by 8.33 percentage points. This sharp single-session advance stands out as a stock-specific event amid a broadly subdued market backdrop.

Fischer Medical Ventures Ltd’s stock price declined to a fresh 52-week low of Rs.32 on 09 June 2026, marking a significant downturn for the commodity chemicals company amid a sustained negative trend over recent weeks.

Fischer Medical Ventures Ltd’s stock price declined to a fresh 52-week low of Rs 32 on 8 June 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and the broader market, reflecting ongoing challenges in profitability and valuation metrics.

Fischer Medical Ventures Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, prompting a downgrade from Hold to Sell by MarketsMOJO on 28 April 2026. The stock’s price has declined sharply, reflecting deteriorating technical indicators and a bearish outlook across multiple timeframes.

At Rs 34.43, sellers were still queuing — but there were no buyers willing to take the other side. Fischer Medical Ventures Ltd locked at its lower circuit of 3.78% on 2 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a thinly traded small-cap stock.

Fischer Medical Ventures Ltd commenced trading on 2 June 2026 with a pronounced gap down, opening 5.0% lower than its previous close. This weak start reflects ongoing market apprehensions, with the stock underperforming its sector and broader indices amid a continuation of recent declines.

Fischer Medical Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

At Rs 36.24, sellers were still queuing — but there were no buyers willing to take the other side. Fischer Medical Ventures Ltd locked at its lower circuit of 4.98% on 1 Jun 2026, with unfilled sell orders and a frozen price.

Fischer Medical Ventures Ltd., a small-cap commodity chemicals player transitioning into medical imaging technology trading, reported a jarring reversal in Q4 FY26, posting a consolidated net loss of ₹7.10 crores compared to a profit of ₹19.23 crores in the previous quarter—a staggering 136.92% quarter-on-quarter decline. Despite net sales of ₹97.73 crores representing a robust 98.76% year-on-year growth, the company's profitability collapsed under the weight of surging interest costs and margin compression. The stock, trading at ₹38.11 on May 29, 2026, has tumbled 56.45% over the past year, significantly underperforming both the Sensex and its commodity chemicals sector peers.

At Rs 38.3, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Fischer Medical Ventures Ltd locked at its upper circuit of 3.62% on 25 May 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 36.49, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Fischer Medical Ventures Ltd locked at its upper circuit of 4.95% on 21 May 2026, with buyers queuing and no sellers willing to part with shares.

Fischer Medical Ventures Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Fischer Medical Ventures Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 Apr 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.